Solventum Q1 GAAP Net Income Plunges 90% to $13M, EPS Down 91%
summarizeSummary
Solventum Corp reported first-quarter 2026 GAAP revenue of $2.01 billion, a 3% year-over-year decline. Net income plummeted 90.5% to $13 million, resulting in diluted EPS of $0.07, down 91% from the prior-year quarter. This 10-Q summary provides a critical counterpoint to earlier news today that highlighted a 10.6% increase in adjusted diluted EPS and positive organic sales growth guidance. The significant year-over-year declines in GAAP profitability metrics reveal substantial underlying challenges, which could raise concerns about the quality of earnings and operational efficiency. Traders will be closely examining the reconciliation between GAAP and adjusted figures for any significant non-recurring items or adjustments that are masking core profitability issues.
At the time of this announcement, SOLV was trading at $67.07 on NYSE in the Life Sciences sector, with a market capitalization of approximately $12B. The 52-week trading range was $62.38 to $88.20. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.